Market Overview:
The global autoinjectors market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in autoinjectors. Based on type, the disposable autoinjectors segment is expected to account for the largest share of the global autoinjectors market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. The large share and high growth rate of this segment can be attributed to factors such as increasing preference for disposable devices over reusable devices and growing awareness about self-administration of drugs among patients with chronic diseases. Based on application, anaphylaxis is estimated to account for the largest share of the global autoinjectors market in 2018.
Product Definition:
Autoinjectors are devices that inject a pre-measured dose of medication into the body. They are often used to treat conditions such as anaphylaxis, which is a life-threatening allergic reaction. Autoinjectors can be very important for people with severe allergies, as they can provide them with an immediate dose of epinephrine (a hormone that helps to reverse the effects of anaphylaxis).
Disposable Auto-Injectors:
Disposable auto-injectors are a class of drug delivery devices that consist of one or more injectable drugs, which is usually administered by a healthcare professional. The device consists of an injection pen, which is used to deliver the medication through the skin. It’s most commonly used for patients who are unable to use reusable auto-injectors or have difficulty in manual injection techniques due to weak hand and arm muscles.
Reusable Auto-Injectors:
Reusable auto-injectors are devices that are intended for the administration of vaccines and other medications. They can be used multiple times without being disposed of after use. Reusable auto-injectors offer various advantages such as they reduce waste generated from packaging materials, they help in reducing cost associated with packaging material, and it helps to minimize the risk of contamination by eliminating the need for sterilization during its usage.
Application Insights:
Anaphylaxis was the most prominent application segment in the global autoinjectors market in 2017. Anaphylaxis is a severe allergic reaction to a substance that occurs due to an over-reaction of the immune system. The World Allergy Organization (WRO) states that approximately 50 million people are affected by allergies worldwide, of which about 30 million suffer from severe reactions known as anaphylactic shock. Thus, increasing incidence of anaphylaxis and other allergy-related disorders is expected to drive demand for autoinjectors during the forecast period.
Rheumatoid arthritis was another prominent application segment owing to high prevalence of rheumatoid arthritis and other associated conditions such as osteoarthritis and osteoporosis, which occur due to joint inflammation for a long time period or permanent disability caused by rheumatoid arthritis or any other autoimmune disease.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable government initiatives, and increasing prevalence of chronic conditions are some factors responsible for its large share. For instance, in December 2016, Mylan acquired BIM23AID to expand its product portfolio for anaphylaxis treatment and prevention.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to rising healthcare expenditure by governments as well as private sectors in countries such as China and India. In addition, growing awareness about autoinjectors among patients is anticipated to fuel the demand during the forecast period.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. Autoinjectors are increasingly becoming an important part of the treatment regimen for patients with chronic diseases, as they offer a convenient and safe way to administer medication.
- Growing demand for self-injection devices: There is a growing demand for self-injection devices, especially among patients with chronic conditions who require regular injections. Autoinjectors offer a fast, easy, and safe way to inject medication without having to go to a doctor or nurse every time you need an injection. This has led to increased adoption of autoinjectors in recent years.
- Technological advancements: The autoinjector market is constantly evolving with new technological advancements being made in this field on a regular basis. These advancements are helping manufacturers create better and more user-friendly autoinjectors that can be used by people from all walks of life safely and effectively. This is likely to lead to increased adoption rates for autoinjectors in the coming years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Autoinjectors Market Research Report
By Type
Disposable Auto-Injectors, Reusable Auto-Injectors
By Application
Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others
By Companies
Mylan, BD, Johnson & Johnson, Amgen Inc., Eli Lilly, Biogen Idec, Mylan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Autoinjectors Market Report Segments:
The global Autoinjectors market is segmented on the basis of:
Types
Disposable Auto-Injectors, Reusable Auto-Injectors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan
- BD
- Johnson & Johnson
- Amgen Inc.
- Eli Lilly
- Biogen Idec
- Mylan
Highlights of The Autoinjectors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Disposable Auto-Injectors
- Reusable Auto-Injectors
- By Application:
- Anaphylaxis
- Multiple Sclerosis
- Rheumatoid Arthritis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Autoinjectors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Autoinjectors are devices that automatically inject a pre-measured dose of medication into the body when activated. They are typically used to administer medications in an emergency situation, such as during surgery.
Some of the major companies in the autoinjectors market are Mylan, BD, Johnson & Johnson, Amgen Inc., Eli Lilly, Biogen Idec, Mylan.
The autoinjectors market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Autoinjectors Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Autoinjectors Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Autoinjectors Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Autoinjectors Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Autoinjectors Market Size & Forecast, 2020-2028 4.5.1 Autoinjectors Market Size and Y-o-Y Growth 4.5.2 Autoinjectors Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Disposable Auto-Injectors
5.2.2 Reusable Auto-Injectors
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Anaphylaxis
6.2.2 Multiple Sclerosis
6.2.3 Rheumatoid Arthritis
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Autoinjectors Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Autoinjectors Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Disposable Auto-Injectors
9.6.2 Reusable Auto-Injectors
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Anaphylaxis
9.10.2 Multiple Sclerosis
9.10.3 Rheumatoid Arthritis
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Disposable Auto-Injectors
10.6.2 Reusable Auto-Injectors
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Anaphylaxis
10.10.2 Multiple Sclerosis
10.10.3 Rheumatoid Arthritis
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Disposable Auto-Injectors
11.6.2 Reusable Auto-Injectors
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Anaphylaxis
11.10.2 Multiple Sclerosis
11.10.3 Rheumatoid Arthritis
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Disposable Auto-Injectors
12.6.2 Reusable Auto-Injectors
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Anaphylaxis
12.10.2 Multiple Sclerosis
12.10.3 Rheumatoid Arthritis
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Disposable Auto-Injectors
13.6.2 Reusable Auto-Injectors
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Anaphylaxis
13.10.2 Multiple Sclerosis
13.10.3 Rheumatoid Arthritis
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Autoinjectors Market: Competitive Dashboard
14.2 Global Autoinjectors Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mylan
14.3.2 BD
14.3.3 Johnson & Johnson
14.3.4 Amgen Inc.
14.3.5 Eli Lilly
14.3.6 Biogen Idec
14.3.7 Mylan